GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (STU:LSI) » Definitions » Price-to-Operating-Cash-Flow

CK Life Sciences International Holdings (STU:LSI) Price-to-Operating-Cash-Flow : 8.42 (As of May. 16, 2024)


View and export this data going back to . Start your Free Trial

What is CK Life Sciences International Holdings Price-to-Operating-Cash-Flow?

As of today (2024-05-16), CK Life Sciences International Holdings's share price is €0.0505. CK Life Sciences International Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.01. Hence, CK Life Sciences International Holdings's Price-to-Operating-Cash-Flow Ratio for today is 8.42.

The historical rank and industry rank for CK Life Sciences International Holdings's Price-to-Operating-Cash-Flow or its related term are showing as below:

STU:LSI' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.04   Med: 19.74   Max: 44.29
Current: 8.58

During the past 13 years, CK Life Sciences International Holdings's highest Price-to-Operating-Cash-Flow Ratio was 44.29. The lowest was 6.04. And the median was 19.74.

STU:LSI's Price-to-Operating-Cash-Flow is ranked better than
85.91% of 291 companies
in the Biotechnology industry
Industry Median: 26.35 vs STU:LSI: 8.58

CK Life Sciences International Holdings's Cash Flow from Operations per share for the six months ended in Dec. 2023 was €0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.01.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of CK Life Sciences International Holdings was 39.50% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -1.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 11.00% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 5.60% per year.

During the past 13 years, CK Life Sciences International Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was 57.80% per year. The lowest was -25.60% per year. And the median was 3.75% per year.


CK Life Sciences International Holdings Price-to-Operating-Cash-Flow Historical Data

The historical data trend for CK Life Sciences International Holdings's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings Price-to-Operating-Cash-Flow Chart

CK Life Sciences International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.31 16.18 16.82 20.79 11.70

CK Life Sciences International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.82 - 20.79 - 11.70

Competitive Comparison of CK Life Sciences International Holdings's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, CK Life Sciences International Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CK Life Sciences International Holdings's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's Price-to-Operating-Cash-Flow falls into.



CK Life Sciences International Holdings Price-to-Operating-Cash-Flow Calculation

CK Life Sciences International Holdings's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.0505/0.006
=8.42

CK Life Sciences International Holdings's Share Price of today is €0.0505.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CK Life Sciences International Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

CK Life Sciences International Holdings Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


CK Life Sciences International Holdings (STU:LSI) Business Description

Traded in Other Exchanges
Address
2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.